Role of Bacillus Clausii in Prevention of Antibiotic Associated Diarrhea in Pediatrics
DOI:
https://doi.org/10.59675/U229Keywords:
Antibiotic-associated diarrhea (AAD), Antimicrobials, Probiotics, Pediatric population, Bacillus clausiiAbstract
Antibiotic-associated diarrhea (AAD) occurs when prescribers are compelled to use antimicrobials for appropriate medical indications. Although awareness about AAD has increased during the past 40 years, no single or combined therapy has been found to effectively prevent it or help in rapid recovery from it in the pediatric age group. Therefore, the present interest in probiotics due to the catastrophic effects of the overuse of antibiotics and the need to curtail the problem of AAD in the growing pediatric population. Many probiotics have the potential to be effective for the prevention of AAD, yet the bacterial spore Bacillus clausii stands out among them as the antibiotic can be administered concurrently with the antibiotic therapy. The safety and efficacy profile of Bacillus clausii speak for itself; it is not surprising that it is one of the most common probiotics used in pediatric practice. However, a few doubts linger due to the half-decade of exploitation in clinical work and capsule formulation
Downloads
References
Kopacz K, Phadtare S, editors. Probiotics for the prevention of antibiotic-associated diarrhea2022: MDPI. DOI: https://doi.org/10.3390/healthcare10081450
Maity C, Gupta AK. Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: a randomized controlled trial. Heliyon. 2021;7(9). DOI: https://doi.org/10.1016/j.heliyon.2021.e07993
Lames H. ALManseeqanaa, Mohammed Razzak Ali, Raed H. Ogaili. The Activity of Nourseothricin Against Drug-Resistant Bacteria. Aca. Intl. J. Med. Sci. ;1(2):18-27.DOI:https://doi.org/10.59675/M124 DOI: https://doi.org/10.59675/M124
Nisreen Jawad Kadhim, Raed H. Ogaili, Asaad Abbas. Intestinal Bacterial Microbiota In Irritable Bowel Syndrome. Aca. Intl. J. P. Sci.;1(1):1-6. DOI; https://doi.org/10.59675/P111 DOI: https://doi.org/10.59675/P111
Radlović N, Leković Z, Vuletić B, Radlović V, Simić D. Acute diarrhea in children. Srpski arhiv za celokupno lekarstvo. 2015;143(11-12):755-62. DOI: https://doi.org/10.2298/SARH1512755R
Guo H, Yu L, Tian F, Zhao J, Zhang H, Chen W, et al. Effects of Bacteroides-based microecologics against antibiotic-associated diarrhea in mice. Microorganisms. 2021;9(12):2492. DOI: https://doi.org/10.3390/microorganisms9122492
do Carmo MS, itapary dos Santos C, Araújo MC, Girón JA, Fernandes ES, Monteiro-Neto V. Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children. Food & function. 2018;9(10):5074-95. DOI: https://doi.org/10.1039/C8FO00376A
Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ open. 2021;11(8):e043054. DOI: https://doi.org/10.1136/bmjopen-2020-043054
De Castro J-A, Kesavelu D, Lahiri KR, Chaijitraruch N, Chongsrisawat V, Jog PP, et al. Recommendations for the adjuvant use of the poly-antibiotic–resistant probiotic Bacillus clausii (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts. Tropical diseases, travel medicine and vaccines. 2020;6:1-15. DOI: https://doi.org/10.1186/s40794-020-00120-4
Liao W, Chen C, Wen T, Zhao Q. Probiotics for the prevention of antibiotic-associated diarrhea in adults: a meta-analysis of randomized placebo-controlled trials. Journal of clinical gastroenterology. 2021;55(6):469-80. DOI: https://doi.org/10.1097/MCG.0000000000001464
Cai J, Zhao C, Du Y, Zhang Y, Zhao M, Zhao Q. Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis. United European gastroenterology journal. 2018;6(2):169-80. DOI: https://doi.org/10.1177/2050640617736987
Ianiro G, Rizzatti G, Plomer M, Lopetuso L, Scaldaferri F, Franceschi F, et al. Bacillus clausii for the treatment of acute diarrhea in children: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2018;10(8):1074. DOI: https://doi.org/10.3390/nu10081074
Maity C, Gupta AK. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort. European Journal of Clinical Pharmacology. 2019;75:21-31. DOI: https://doi.org/10.1007/s00228-018-2562-x
de Castro J-AA, Guno MJV-R, Perez MO. Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE). Tropical diseases, travel medicine and vaccines. 2019;5:1-9. DOI: https://doi.org/10.1186/s40794-019-0089-5
Tringali A, Thomson M, Dumonceau J-M, Tavares M, Tabbers MM, Furlano R, et al. Pediatric gastrointestinal endoscopy: European society of gastrointestinal endoscopy (ESGE) and European society for paediatric gastroenterology hepatology and nutrition (ESPGHAN) guideline executive summary. Endoscopy. 2017;49(01):83-91. DOI: https://doi.org/10.1055/s-0042-111002
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Academic International Journal of Medical Update
This work is licensed under a Creative Commons Attribution 4.0 International License.
